PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING SEIZURE DISORDERS

The present disclosure relates to the transdermal administration of cannabidiol (CBD) for the reduction of seizure frequency in the treatment of "treatment-resistant epilepsy" (TRE).

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LATHER, Tamanna, BOROVINSKAYA, Marina, MODI, Nisarg, PLAKOGIANNIS, Fotios M
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to the transdermal administration of cannabidiol (CBD) for the reduction of seizure frequency in the treatment of "treatment-resistant epilepsy" (TRE).